Simply Wall St.
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors
📈
AI Sentiment
Highly Positive
8/10
- Home
- IDXX
as of 02-18-2026 3:51pm EST
$636.52
+$10.35
+1.65%
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
| Founded: | 1983 | Country: | N/A |
| Employees: | N/A | City: | WESTBROOK |
| Market Cap: | 57.1B | IPO Year: | N/A |
| Target Price: | $715.00 | AVG Volume (30 days): | 546.7K |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $356.14 - $769.98 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 10.81% | Revenue Growth (next year): | 8.62% |
| P/E Ratio: | 47.87 | Index: | |
| Free Cash Flow: | N/A | FCF Growth: | +30.82% |
AI-Powered IDXX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 77.78%
77.78%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of IDEXX Laboratories Inc. (IDXX)
FENNELL GEORGE
Sell
Executive Vice President
IDXX Feb 10, 2026
Avg Cost/Share
$646.76
Shares
11,345
Total Value
$7,336,993.27
Owned After
20,038
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| FENNELL GEORGE | IDXX | Executive Vice President | Feb 10, 2026 | Sell | $646.76 | 11,345 | $7,336,993.27 | 20,038 |
Latest IDEXX Laboratories Inc. News
IDXX Breaking Stock News: Dive into IDXX Ticker-Specific Updates for Smart Investing
Insider Monkey
IDEXX Laboratories Inc. (IDXX) Shows Resilience as Analysts Reassess Targets
📊
AI Sentiment
Positive
7/10
Business Wire
IDEXX Laboratories to Present at Two Institutional Investor Conferences
📊
AI Sentiment
Positive
7/10
Compare IDXX vs Leading Stocks
See how IDXX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IDXX IDEXX Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.